Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
APRIL 2023LIFE SCIENCES REVIEW9they are provided with the full suite of digital tools to manage their sales pipeline, address customers' ongoing challenges and communicate with them. This is where digital transformation powered by AI becomes key to the success of this new business operation.A New Augmented Intelligence ApproachIf your brand has 30 sales reps, 10 medical science liaisons (MSLs) and 5 patient support liaisons (PSLs) and they operate as individual mini-businesses, you're looking at a model where you are responsible for orchestrating daily activities of about 150 teams consisting of customer-facing experts who often don't interact on a daily basis and sometimes are not even aware they need to work together. This is where digital technology and AI come into play. Through an integrated and seamless CRM interface powered by hyper-personalized algorithms, a sales rep, an MSL, or a PSL can see which physician accounts they need to attend to and for what reason. The AI identifies specific customer pain points, suggests the best intervention, and the team acts on it. If a clinical study has just come out and it's important to increase awareness of new data, an MSL can make the first visit to the doctor and tell her about the results of a trial. AI then assigns the next steps to the sales rep covering the same account based on the outcomes of a medical discussion and anticipated needs from the physician. A recent HBR article authored by a famous chess grandmaster Garry Kasparov and a behavioral science scholar David De Cremer calls this human-machine collaboration Augmented Intelligence.Because customer account teams can drive their own marketing plan, they have access to a suite of digital marketing tools with AI-driven recommendations about the next best action and automated marketing cadences that account owners can trigger. Everyone on the same account team can see what activities their customer has engaged in, in-person or virtual. This AI-driven customer-centric approach puts the frontline teams in the driving seat and elevates the role of sales, medical and patient support associates. It also focuses on building a trusting relationship with the customer and emphasizes supporting their needs through coordinated and optimized engagement.As an additional benefit, a solid strategy with the right amount of support makes each account owner less likely to leave the company because, in this new model, the solution is provided by the entire account team rather than by an individual. The long term benefit of retaining key talent is undeniable.In the new customer-centric reality pharma industry is moving towards AI, and digital technology does not replace sales, medical or patient support reps. Instead, they amplify one's ability to build long-lasting relationships with the customer and move the conversation from selling to creating value. Year over year, pharma companies continue to shed their field force headcount while struggling to replace it with automated non-personal engagement with the customer
< Page 8 | Page 10 >